APA

Loveday C., Litchfield K., Levy M., Holroyd A., Broderick P., Kote-Jarai Z., Dunning A. M., Muir K., Peto J., Eeles R., Easton D. F., Dudakia D., Orr N., Pashayan N., Reid A., Huddart R. A., Houlston R. S. & Turnbull C. (2018). Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer. : Oncotarget.

Chicago

Loveday Chey, Litchfield Kevin, Levy Max, Holroyd Amy, Broderick Peter, Kote-Jarai Zsofia, Dunning Alison M, Muir Kenneth, Peto Julian, Eeles Rosalind, Easton Douglas F, Dudakia Darshna, Orr Nick, Pashayan Nora, Reid Alison, Huddart Robert A, Houlston Richard S and Turnbull Clare. 2018. Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer. : Oncotarget.

Harvard

Loveday C., Litchfield K., Levy M., Holroyd A., Broderick P., Kote-Jarai Z., Dunning A. M., Muir K., Peto J., Eeles R., Easton D. F., Dudakia D., Orr N., Pashayan N., Reid A., Huddart R. A., Houlston R. S. and Turnbull C. (2018). Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer. : Oncotarget.

MLA

Loveday Chey, Litchfield Kevin, Levy Max, Holroyd Amy, Broderick Peter, Kote-Jarai Zsofia, Dunning Alison M, Muir Kenneth, Peto Julian, Eeles Rosalind, Easton Douglas F, Dudakia Darshna, Orr Nick, Pashayan Nora, Reid Alison, Huddart Robert A, Houlston Richard S and Turnbull Clare. Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer. : Oncotarget. 2018.